143 related articles for article (PubMed ID: 35818194)
1. LncRNA-MALAT 1 regulates cardiomyocyte scorching in diabetic cardiomyopathy by targeting NLRP3.
Shi C; Wu L; Li L
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(6):213-219. PubMed ID: 35818194
[TBL] [Abstract][Full Text] [Related]
2. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Li A; Lv J; Sun X; Che H; Han T; Meng S; Bai Y; Wang L
Cell Physiol Biochem; 2018; 50(4):1230-1244. PubMed ID: 30355944
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
4. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR.
Xu Y; Fang H; Xu Q; Xu C; Yang L; Huang C
Cell Cycle; 2020 Nov; 19(22):3054-3065. PubMed ID: 33092444
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
[TBL] [Abstract][Full Text] [Related]
6. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DCRF regulates cardiomyocyte autophagy by targeting miR-551b-5p in diabetic cardiomyopathy.
Feng Y; Xu W; Zhang W; Wang W; Liu T; Zhou X
Theranostics; 2019; 9(15):4558-4566. PubMed ID: 31285779
[No Abstract] [Full Text] [Related]
8. Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome.
Peng M; Liu Y; Xu Y; Li L; Li Y; Yang H
Cell Cycle; 2021 Nov; 20(21):2278-2290. PubMed ID: 34585633
[TBL] [Abstract][Full Text] [Related]
9. Silencing of peroxisome proliferator-activated receptor-alpha alleviates myocardial injury in diabetic cardiomyopathy by downregulating 3-hydroxy-3-methylglutaryl-coenzyme A synthase 2 expression.
Wang L; Bi X; Han J
IUBMB Life; 2020 Sep; 72(9):1997-2009. PubMed ID: 32734614
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
Xu D; Zhang X; Chen X; Yang S; Chen H
Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 attenuates high glucose-induced cardiomyocyte apoptosis via regulation of miR-181a-5p.
Cheng Y; Li J; Wang C; Yang H; Wang Y; Zhan T; Guo S; Liang J; Bai Y; Yu J; Liu G
Exp Anim; 2020 Jan; 69(1):34-44. PubMed ID: 31353329
[TBL] [Abstract][Full Text] [Related]
12. Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Yao J; Li Y; Jin Y; Chen Y; Tian L; He W
Int Immunopharmacol; 2021 Jul; 96():107728. PubMed ID: 33971494
[TBL] [Abstract][Full Text] [Related]
13. Puerarin Inhibits NLRP3-Caspase-1-GSDMD-Mediated Pyroptosis via P2X7 Receptor in Cardiomyocytes and Macrophages.
Sun S; Gong D; Liu R; Wang R; Chen D; Yuan T; Wang S; Xing C; Lv Y; Du G; Fang L
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685976
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA KCNQ1OT1 increases the expression of PDCD4 by targeting miR-181a-5p, contributing to cardiomyocyte apoptosis in diabetic cardiomyopathy.
Zhao SF; Ye YX; Xu JD; He Y; Zhang DW; Xia ZY; Wang S
Acta Diabetol; 2021 Sep; 58(9):1251-1267. PubMed ID: 33907874
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ROS/Chloride Efflux-Mediated NLRP3 Inflammasome Activation Contributes to Alleviation of Diabetic Cardiomyopathy in Rats after Sleeve Gastrectomy.
Li S; Dong S; Shi B; Xu Q; Li L; Wang S; Zhang W; Zhong M; Zhu J; Cheng Y; Zhang G; Hu S
Oxid Med Cell Longev; 2022; 2022():4608914. PubMed ID: 35498125
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes.
Mangali S; Bhat A; Jadhav K; Kalra J; Sriram D; Vamsi Krishna Venuganti V; Dhar A
Biochem Pharmacol; 2020 Jul; 177():113948. PubMed ID: 32251680
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
Sun H; Wang C; Zhou Y; Cheng X
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy.
Li X; Du N; Zhang Q; Li J; Chen X; Liu X; Hu Y; Qin W; Shen N; Xu C; Fang Z; Wei Y; Wang R; Du Z; Zhang Y; Lu Y
Cell Death Dis; 2014 Oct; 5(10):e1479. PubMed ID: 25341033
[TBL] [Abstract][Full Text] [Related]
20. Krill Oil Inhibits NLRP3 Inflammasome Activation in the Prevention of the Pathological Injuries of Diabetic Cardiomyopathy.
Sun X; Sun X; Meng H; Wu J; Guo X; Du L; Wu H
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
